Climb Bio, Inc. (CLYM) has 3 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $1.4M. Most recent filing: Sept. 17, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 17, 2026 filed Sept. 15, 2026 | Thomas Stephen Basil Director | −$1,366,820 | 100,000 | −18% | Yes | |
|
|
||||||
| July 1, 2026 filed June 29, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | $0 | 70,284 | 0% | No | |
|
|
||||||
| June 30, 2026 filed June 27, 2026 | Brennan Aoife President and CEO | — | +37,848 | +76% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free